Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients

NCT00493896 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

27

Enrollment

OTHER

Sponsor class

Stopped low enrollment

Conditions

Venous Thromboembolism

Interventions

DRUG: Fondaparinux
DRUG: Enoxaparin

Sponsor

Eastern Virginia Medical School

Collaborators

[object Object]